CoChat

Hypoxia promotes acquisition of aggressive phenotypes in human malignant mesothelioma

Open access

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Hypoxia is a hallmark of the solid tumor microenvironment and is associated with poor outcomes in cancer patients. The present study was performed to investigate mechanisms underlying the hypoxia-induced phenotypic changes using human malignant mesothelioma (HMM) cells. METHODS: Hypoxic conditions were achieved by incubating HMM cells in the air chamber. The effect of hypoxia on phenotype changes in HMM cells was investigated by performing in vitro clonogenicity, drug resistance, migration, and invasion assays. Signaling pathways and molecules involved in the more aggressive behaviors of HMM cells under hypoxia were investigated. A two-tailed unpaired Student's t-test or one-way ANOVA with Bonferroni post-test correction was used in this study. RESULTS: Hypoxic conditions upregulated hypoxia-inducible factor 1 alpha (HIF-1α) and HIF-2α in parallel with the upregulation of its target, Glut-1, in HMM cells. In vitro clonogenicity of HMM cells was significantly increased in hypoxic conditions, but the proliferation of cells at a high density in hypoxia was lower than that in normoxic conditions. The expression levels of HIF-2α and Oct4 were increased in hypoxic HMM cells. The percentage of cells with high CD44 expression was significantly higher in HMM cells cultured in hypoxia than those cultured in normoxia. Hypoxia significantly enhanced the resistance of HMM cells to cisplatin, which occurred through cytoprotection against cisplatin-induced apoptosis. While cisplatin treatment decreased the ratio of Bcl-2 to Bax in normoxic condition, hypoxia conversely increased the ratio in HMM cells treated with cisplatin. Hypoxia increased the mobility and invasiveness of HMM cells. Epithelial to mesenchymal transition was promoted, which was indicated by the repression of E-cadherin and the concomitant increase of vimentin in HMM cells. CONCLUSIONS: The data illustrated that hypoxic conditions augmented the aggressive phenotypes of HMM cells at the biological and molecular levels. The present study provides valuable background information beginning to understand aggressiveness of HMM in tumor microenvironments, suggesting that a control measure for tumor hypoxia may be an effective therapeutic strategy to reduce the aggressiveness of cancer cells in HMM patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12885-018-4720-z

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 The experimental establishment of tumor hypoxia in HMM cells. (a) Hypoxia markedly increased HIF-1α expression and induced HIF-2α expression de novo in HMM cells. (b) A HIF-1/2α target Glut-1 increased in response to hypoxia and glucose starvation in MS1 cells. Abbreviations: N, normoxia; H, hypoxia
Fig. 1 The experimental establishment of tumor hypoxia in HMM cells. (a) Hypoxia markedly increased HIF-1α expression and induced HIF-2α expression de novo in HMM cells. (b) A HIF-1/2α target Glut-1 increased in response to hypoxia and glucose starvation in MS1 cells. Abbreviations: N, normoxia; H, hypoxiaCC BY · PubMed Central
Fig. 2 The effect of hypoxia on in vitro clonogenicity in HMM cells. (a) Hypoxia enhanced the colony forming ability of HMM cells. Representative microscopic examinations are presented. P value was calculated by Student’s t-test. Hypoxia significantly upregulated the expression of Oct4 at transcriptional (b) and translational (c) levels in HMM cells. P value was calculated by one-way ANOVA with Bonferroni post-test. *P value < 0.05, **P value < 0.01. Abbreviations: N, normoxia; H, hypoxia
Fig. 2 The effect of hypoxia on in vitro clonogenicity in HMM cells. (a) Hypoxia enhanced the colony forming ability of HMM cells. Representative microscopic examinations are presented. P value was calculated by Student’s t-test. Hypoxia significantly upregulated the expression of Oct4 at transcriptional (b) and translational (c) levels in HMM cells. P value was calculated by one-way ANOVA with Bonferroni post-test. *P value < 0.05, **P value < 0.01. Abbreviations: N, normoxia; H, hypoxiaCC BY · PubMed Central
Fig. 3 The effect of hypoxia on cell proliferation in HMM cells. Hypoxia significantly decreased proliferation and viability in HMM cells at high cell seeding density. (a) Counting cell numbers. (b) MTT assay. The number of cells initially seeded is presented in parentheses. Cell cycle profiles did not appreciably differ between normoxic and hypoxic HMM cells (c). *P value < 0.05, **P value < 0.01, as calculated by Student’s t-test. Abbreviations: N, normoxia; H, hypoxia
Fig. 3 The effect of hypoxia on cell proliferation in HMM cells. Hypoxia significantly decreased proliferation and viability in HMM cells at high cell seeding density. (a) Counting cell numbers. (b) MTT assay. The number of cells initially seeded is presented in parentheses. Cell cycle profiles did not appreciably differ between normoxic and hypoxic HMM cells (c). *P value < 0.05, **P value < 0.01, as calculated by Student’s t-test. Abbreviations: N, normoxia; H, hypoxiaCC BY · PubMed Central
Fig. 4 The effect of hypoxia on drug sensitivity in HMM cells. MTT assay. The sensitivity to cisplatin was decreased in HMM cells under hypoxia for 24 h (a) and 48 h (b), compared to the sensitivity of those in normoxia. * indicates a significant difference compared with the corresponding normoxic cisplatin-treated control. *P value < 0.05, **P value < 0.01, as calculated by Student’s t-test
Fig. 4 The effect of hypoxia on drug sensitivity in HMM cells. MTT assay. The sensitivity to cisplatin was decreased in HMM cells under hypoxia for 24 h (a) and 48 h (b), compared to the sensitivity of those in normoxia. * indicates a significant difference compared with the corresponding normoxic cisplatin-treated control. *P value < 0.05, **P value < 0.01, as calculated by Student’s t-testCC BY · PubMed Central
Fig. 5 The effect of hypoxia on cisplatin-induced apoptosis in HMM cells. (a) Hypoxia significantly reduced apoptosis either with or without cisplatin in HMM cells. (b) Hypoxia upregulated the expression of anti-apoptotic Bcl-2, whereas Bcl-xL levels remained almost unchanged in HMM cells. Marked increase in pro-apoptotic Bax expression was detected in MS1 cells only. The ratio of Bcl-2 and Bcl-xL to Bax increased in H513 cells. (c) Hypoxia increased Bcl-2 levels and maintained the expression during exposure to cisplatin treatment in HMM cells, compared to the expression level in cells in normoxia. With cisplatin treatment, Bcl-xL expression either tended to decrease or remained unchanged in HMM cells under hypoxia, compared to the level in cells in normoxia. The cisplatin-induced increase in Bax expression was less under hypoxia than under normoxia in MS1 cells. The Bcl-2 to Bax ratio increased in HMM cells under hypoxia following cisplatin. All protein expression was normalized to endogenous β-actin level and is presented as densitometric values at the top of each protein blot. *P value < 0.05, as calculated by one-way ANOVA with Bonferroni post-test
Fig. 5 The effect of hypoxia on cisplatin-induced apoptosis in HMM cells. (a) Hypoxia significantly reduced apoptosis either with or without cisplatin in HMM cells. (b) Hypoxia upregulated the expression of anti-apoptotic Bcl-2, whereas Bcl-xL levels remained almost unchanged in HMM cells. Marked increase in pro-apoptotic Bax expression was detected in MS1 cells only. The ratio of Bcl-2 and Bcl-xL to Bax increased in H513 cells. (c) Hypoxia increased Bcl-2 levels and maintained the expression during exposure to cisplatin treatment in HMM cells, compared to the expression level in cells in normoxia. With cisplatin treatment, Bcl-xL expression either tended to decrease or remained unchanged in HMM cells under hypoxia, compared to the level in cells in normoxia. The cisplatin-induced increase in Bax expression was less under hypoxia than under normoxia in MS1 cells. The Bcl-2 to Bax ratio increased in HMM cells under hypoxia following cisplatin. All protein expression was normalized to endogenous β-actin level and is presented as densitometric values at the top of each protein blot. *P value < 0.05, as calculated by one-way ANOVA with Bonferroni post-testCC BY · PubMed Central
Fig. 6 The effect of hypoxia on migration and invasion in HMM cells. (a) Hypoxia significantly increased migration in HMM cells. (b) Hypoxia significantly enhanced invasion in H513 cells. (c) Phase contrast images (400× magnification) of HMM cells cultured for 48 h under normoxia or hypoxia are presented. (d) Hypoxia induced a loss of E-cadherin expression and a gain of vimentin expression in HMM cells. E-cadherin expression was not detected in MS1 cells. *P value < 0.05, as calculated by Student’s t-test
Fig. 6 The effect of hypoxia on migration and invasion in HMM cells. (a) Hypoxia significantly increased migration in HMM cells. (b) Hypoxia significantly enhanced invasion in H513 cells. (c) Phase contrast images (400× magnification) of HMM cells cultured for 48 h under normoxia or hypoxia are presented. (d) Hypoxia induced a loss of E-cadherin expression and a gain of vimentin expression in HMM cells. E-cadherin expression was not detected in MS1 cells. *P value < 0.05, as calculated by Student’s t-testCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Show all 45 references

Research works printed but not linked: 1

  1. Klabatsa A Sheaff M Steele J Evans M Rudd R Fennell D Expression and prognostic significance of hypoxia-inducible factor 1α (HIF-1α) in malignant pleural mesothelioma (MPM) Lung Cancer 2006 51 1 53 59 10.1016/j.lungcan.2005.07.010 16169121 · DOI · Paper page

Cited by

See all 52

Metadata

Authors
Kim, M.-C., Hwang, S.-H., Kim, N.-Y., Lee, H.-S., Ji, S., Yang, Y., & Kim, Y.
Affiliations
Seoul National University (KR)
Corresponding author
Kim, Yongbaek
Venue
BMC Cancer
Published
2018-08-15
Volume
18
Issue
1
Pages
819-819
ISSN
1471-2407 (ISSN-L)
OpenAlex
W2885732541
Cited by
49
References
45
Citations by year
2026: 3 · 2025: 6 · 2024: 6 · 2023: 4 · 2022: 3 · 2021: 9 · 2020: 7 · 2019: 11
FWCI
2.04
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/4.0/ (tdm)
Locations
  • BMC Cancer (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Seoul National University Open Repository (Seoul National University) (submittedVersion)
Funders
National Research Foundation of Korea (2017R1A2B4008119)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords
malignant mesothelioma, tumor hypoxia, HIF-1α, HIF-2α, Oct4, CD44, cisplatin resistance, apoptosis, Bcl-2/Bax ratio, epithelial-mesenchymal transition, cell migration and invasion, clonogenicity, tumor microenvironment, GLUT1
MeSH terms
Tumor Hypoxia, Mesothelioma, Malignant, Endothelial PAS Domain-Containing Protein 1, Cell Movement, Humans, Lung Neoplasms, Mesothelioma, Signal Transduction, Gene Expression Regulation, Neoplastic, Apoptosis, Cell Line, Tumor, Cell Proliferation, Octamer Transcription Factor-3, Glucose Transporter Type 1, Basic Helix-Loop-Helix Proteins, Hypoxia-Inducible Factor 1, alpha Subunit, Epithelial-Mesenchymal Transition, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hypoxia promotes acquisition of aggressive phenotypes in human malignant mesothelioma. https://app.cochat.ai/papers/10.1186/s12885-018-4720-z
The paper
Kim, M.-C., Hwang, S.-H., Kim, N.-Y., Lee, H.-S., Ji, S., Yang, Y., & Kim, Y. (2018). Hypoxia promotes acquisition of aggressive phenotypes in human malignant mesothelioma. BMC Cancer. https://doi.org/10.1186/s12885-018-4720-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.